Detalles de la búsqueda
1.
Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina.
Clinicoecon Outcomes Res
; 15: 513-523, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37405360
2.
Antibiotic Utilization during COVID-19: Are We Over-Prescribing?
Antibiotics (Basel)
; 12(2)2023 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830218
3.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37065720
4.
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance.
Expert Rev Anti Infect Ther
; 21(10): 1025-1055, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740561
5.
Self-medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior.
Pharmacoepidemiol Drug Saf
; 21(10): 1130-3, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22334375
6.
Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up.
Front Pharmacol
; 13: 889047, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35784727
7.
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.
Front Pharmacol
; 13: 873556, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35865969
8.
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.
Expert Rev Anti Infect Ther
; 20(1): 71-93, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34038294
9.
Regulation of the apothecary activity in Bosnia and Herzegovina over the Austro-Hungarian period.
Med Glas (Zenica)
; 18(2): 343-351, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33871220
10.
Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications.
Med Access Point Care
; 5: 23992026211027692, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-36204505
11.
Evidence-based public policy making for medicines across countries: findings and implications for the future.
J Comp Eff Res
; 10(12): 1019-1052, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34241546
12.
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries.
Life (Basel)
; 11(6)2021 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34200116
13.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33535841
14.
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Biomed Res Int
; 2021: 9996193, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676266
15.
Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina.
Eur J Clin Pharmacol
; 66(2): 177-86, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19816681
16.
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.
Front Pharmacol
; 11: 591134, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33519450
17.
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.
Curr Med Res Opin
; 36(2): 301-327, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794332
18.
Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study.
Pharmacoepidemiol Drug Saf
; 18(4): 320-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19156752
19.
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Expert Rev Pharmacoecon Outcomes Res
; 19(3): 251-261, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696372
20.
Are pharmacists' good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries.
J Glob Antimicrob Resist
; 13: 240-245, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29414723